Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin and tetracycline in Lebanon (Q43890481)

27 November 2017

Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin and tetracycline in Lebanon (English)

1 reference

27 November 2017

0 references

1 reference

1 reference

1 reference

1 reference

1 reference

Ala I Sharara

1

1 reference

27 November 2017

Marwan Chedid

2

1 reference

27 November 2017

George F Araj

3

1 reference

27 November 2017

Kassem A Barada

4

1 reference

27 November 2017

Fadi H Mourad

5

1 reference

27 November 2017

1 February 2002

1 reference

International Journal of Antimicrobial Agents

27 November 2017

1 reference

27 November 2017

19

1 reference

27 November 2017

2

1 reference

27 November 2017

155-158

1 reference

Evidence for the essential role of Helicobacter pylori in gastric ulcer disease

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Duodenal ulcer treated with Helicobacter pylori eradication: seven-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Clinical economics review: Helicobacter pylori-associated peptic ulcer disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Randomised controlled trial of short term treatment to eradicate Helicobacter pylori in patients with duodenal ulcer

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Peptic ulcer and Helicobacter pylori: eradication and relapse.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Evolution of metronidazole and tetracycline susceptibility pattern in Helicobacter pylori at a hospital in Saudi Arabia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Effect of two different doses of metronidazole and tetracycline in bismuth triple therapy on eradication of Helicobacter pylori and its resistant strains

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Antimicrobial susceptibility test of Helicobacter pylori isolated from Jos, Nigeria

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Distinctiveness of genotypes of Helicobacter pylori in Calcutta, India

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Metronidazole and clarithromycin resistance amongst Helicobacter pylori isolates from a large metropolitan hospital in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Pretreatment antibiotic resistance in Helicobacter pylori infection: results of three randomized controlled studies

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Rapid increase in the prevalence of metronidazole-resistant Helicobacter pylori in the Netherlands

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Antimicrobial susceptibility testing of Helicobacter pylori in a large multicenter trial: the MACH 2 study

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Metronidazole and clarithromycin susceptibility and the subtypes of vacA of Helicobacter pylori isolates in Estonia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bulgaria

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Triple therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer disease: results of a multicentre study in South-East Asia. South-East Asia Multicenter Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Prevalence and demographic determinants of metronidazole resistance by Helicobacter pylori in a large cosmopolitan cohort of Australian dyspeptic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

Addition of metronidazole to rabeprazole-amoxicillin-clarithromycin regimen for Helicobacter pylori infection provides an excellent cure rate with five-day therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2801%2900482-4

7 January 2021

10.1016/S0924-8579(01)00482-4

Identifiers

DOI

1 reference

27 November 2017

1 reference